BioAge Labs Inc. (BIOA) vs Greenwich LifeSciences, Inc. (GLSI)
A side-by-side comparison of BioAge Labs Inc. and Greenwich LifeSciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BIOA
BioAge Labs Inc.
$6.25HealthcareDelayed quote: Oct 6, 2026, 12:00 PM EDT
GLSI
Greenwich LifeSciences, Inc.
$16.60HealthcareDelayed quote: Oct 6, 2026, 11:59 AM EDT
Total return — BIOA vs GLSI
growth of $100 · dividends reinvested · last 2yBIOA -65.3% (-41.1%/yr)GLSI +18.1% (+8.7%/yr)GLSI compounded faster over this window
BIOA GLSI
BIOA vs GLSI: by the numbers
- •GLSI is the larger company ($244M vs $235M market cap).
- •Both run net losses; GLSI's is the smaller (0.00% vs -912.25% net margin).
Metrics side by side
Valuation
| Metric | BIOA | GLSI |
|---|---|---|
| P/S ratio | 22.73 | N/A |
| P/B ratio | 0.63 | 78.17 |
Profitability
| Metric | BIOA | GLSI |
|---|---|---|
| Gross margin | 99.39% | 0.00% |
| Operating margin | -1026.28% | 0.00% |
| Net margin | -912.25% | 0.00% |
| ROE | -25.20% | -695.56% |
| ROIC | -28.14% | -701.55% |
Growth (annualized)
| Metric | BIOA | GLSI |
|---|---|---|
| Total return CAGR (5Y) | N/A | -14.84% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.